No Data
No Data
No Data
No Data
No Data
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high qual
GlobeNewswireApr 25 08:30 ET
Express News | Veru Inc: On April 23, Received Notification Letter From Nasdaq Confirming That Co Regained Compliance
ReutersApr 25 07:17 ET
Express News | Millennium Management LLC Reports 5.2% Passive Stake in Veru Inc as of April 18 - SEC Filing
Moomoo 24/7Apr 24 16:20 ET
LI, VERU and MRIN Among Pre-market Losers
Seeking AlphaApr 19 08:16 ET
Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers
Seeking AlphaApr 18 10:00 ET
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
BenzingaApr 15 14:11 ET
No Data
No Data